期刊文献+

中西医结合治疗中晚期肝癌55例 被引量:2

The Clinical Research of Advanced Liver Cancer Treated with Integrated Traditional Chinese and Western Medicine
下载PDF
导出
摘要 目的:观察中西医结合治疗中晚期肝癌的临床疗效。方法:将110例患者随机分为对照组和观察组,每组各55例。对照组采用常规西医治疗,观察组在对照组的基础上给予扶正解毒通络方治疗。结果:对照组有效率为67.27%,观察组有效率为83.64%,两组有效率比较,差异具有统计学意义(P<0.05)。两组在中医症状、证候积分,生活质量、疼痛积分以及安全性指标上治疗前比较,无显著性差异(P>0.05),而治疗后与治疗前比较,差异具有统计学意义(P<0.05)。结论:中西医结合治疗中晚期肝癌疗效满意。 Objective:To observe the clinical effect of advanced liver cancer treated with integrated traditional Chinese and western medicine. Methods:110 patients with a(Ivaueed liver cancer were randomly divided into the control group and the observation group, with 55 cases in each group. The patients in the control group were treated with conventional western medicine, and thuse in the observatiun group were treated with Fuzheng Jiedu Tongluo Prescription on the basis of the control group treatment. Results: The efficiency of the control group was 67.27% , while that uf the observation group was 83.64% , and the difference between them had statislical significance. Before treatment, there was no clear difference in TCM symptoms, syndrome s(:ores, quality of life, the pain scores and safety indicators( P〉 0. 05 ) ;But after treatment, the difference between them had statistical significance (P 〈0.05 ). Conclusion: Combined treatment of traditional Chinese and Western Medieine had good effect on advaneed liver Callcer,
作者 付亚杰
出处 《河南中医》 2014年第8期1512-1513,共2页 Henan Traditional Chinese Medicine
关键词 中晚期肝癌 扶正解毒通络方 中西医结合疗法 advanced liver cancer Fuzheng Jiedu Tongluo Prescription combined treatment of traditional Chinese and Western Medicine
  • 相关文献

参考文献4

二级参考文献19

  • 1李玉和,李军.虫类对药治疗难治性肾病探析[J].四川中医,2006,24(12):25-26. 被引量:4
  • 2曾南,杨旋,周桢昊,赵璐,罗静.荆芥挥发油对哮喘模型小鼠肺组织炎症介质的影响[J].四川生理科学杂志,2006,28(4):154-156. 被引量:16
  • 3王筠默.中药药理学[M].上海科学技术出版社,1984.104,87,88,91,21,28.
  • 4中华人民共和国卫生部医政司.中国常见恶性肿瘤诊治规范[M](第2版)[M].北京:北京医科大学中国协和医科大学联合出版社,1991.2-3.
  • 5汤猷,杨秉辉.原发性肝癌的研究与进展[M].上海:上海医科大学出版社,1990:302.
  • 6De CC,Lin LJ,Kao ST,et al.Inhibitory effects of Zuo-Jin-Wan andits alkaloidal ingredients on activator protein 1,nuclear factor-κB,and cellular transformation in HepG2 cells[J].Fitoterapia,2011,82(4):696–703.
  • 7Finn RS.Development of molecularly targeted therapies in hepat-ocellular carcinoma:where do we go now?[J].Clin Cancer Res,2010,16(2):390–397.
  • 8Jemal A,Siegel R,Ward E,et al.Cancer statistics,2008[J].CA CancerJ Clin,2008,58(2):71-96.
  • 9Tang ZY.Liver transplantation:A simple inflammation markerpredicts liver cancer prognosis[J].Nat Rev Gastroenterol Hepatol,2011,8(7):367-368.
  • 10Avila MA,Berasain C,Sangro B,et al.New therapies for hepatoc-ellularcarcinoma[J].Oncogene,2006,25(27):3866–3884.

共引文献15

同被引文献34

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部